vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and STIFEL FINANCIAL CORP (SF). Click either name above to swap in a different company.

STIFEL FINANCIAL CORP is the larger business by last-quarter revenue ($1.1B vs $665.5M, roughly 1.7× Natera, Inc.). STIFEL FINANCIAL CORP runs the higher net margin — 23.5% vs 7.1%, a 16.4% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 23.0%). STIFEL FINANCIAL CORP produced more free cash flow last quarter ($369.0M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 21.1%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Stifel Financial Corp. is an American multinational independent investment bank and financial services company created under the Stifel name in July 1983 and listed on the New York Stock Exchange on November 24, 1986. Its predecessor company was founded in 1890 as the Altheimer and Rawlings Investment Company and is headquartered in downtown St. Louis, Missouri.

NTRA vs SF — Head-to-Head

Bigger by revenue
SF
SF
1.7× larger
SF
$1.1B
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+16.8% gap
NTRA
39.8%
23.0%
SF
Higher net margin
SF
SF
16.4% more per $
SF
23.5%
7.1%
NTRA
More free cash flow
SF
SF
$331.1M more FCF
SF
$369.0M
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
21.1%
SF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NTRA
NTRA
SF
SF
Revenue
$665.5M
$1.1B
Net Profit
$47.3M
$264.4M
Gross Margin
Operating Margin
-3.4%
27.3%
Net Margin
7.1%
23.5%
Revenue YoY
39.8%
23.0%
Net Profit YoY
187.9%
8.3%
EPS (diluted)
$0.36
$2.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
SF
SF
Q4 25
$665.5M
$1.1B
Q3 25
$592.2M
$962.6M
Q2 25
$546.6M
$838.9M
Q1 25
$501.8M
$842.5M
Q4 24
$476.1M
$916.0M
Q3 24
$439.8M
$810.9M
Q2 24
$413.4M
$798.9M
Q1 24
$367.7M
$768.1M
Net Profit
NTRA
NTRA
SF
SF
Q4 25
$47.3M
$264.4M
Q3 25
$-87.5M
$211.4M
Q2 25
$-100.9M
$155.1M
Q1 25
$-66.9M
$53.0M
Q4 24
$-53.8M
$244.0M
Q3 24
$-31.6M
$158.5M
Q2 24
$-37.5M
$165.3M
Q1 24
$-67.6M
$163.6M
Operating Margin
NTRA
NTRA
SF
SF
Q4 25
-3.4%
27.3%
Q3 25
-16.5%
29.7%
Q2 25
-20.2%
25.5%
Q1 25
-15.8%
7.5%
Q4 24
-13.6%
29.1%
Q3 24
-8.9%
26.7%
Q2 24
-10.6%
28.4%
Q1 24
-20.2%
28.5%
Net Margin
NTRA
NTRA
SF
SF
Q4 25
7.1%
23.5%
Q3 25
-14.8%
22.0%
Q2 25
-18.5%
18.5%
Q1 25
-13.3%
6.3%
Q4 24
-11.3%
26.6%
Q3 24
-7.2%
19.5%
Q2 24
-9.1%
20.7%
Q1 24
-18.4%
21.3%
EPS (diluted)
NTRA
NTRA
SF
SF
Q4 25
$0.36
$2.30
Q3 25
$-0.64
$1.84
Q2 25
$-0.74
$1.34
Q1 25
$-0.50
$0.39
Q4 24
$-0.41
$2.10
Q3 24
$-0.26
$1.34
Q2 24
$-0.30
$1.41
Q1 24
$-0.56
$1.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
SF
SF
Cash + ST InvestmentsLiquidity on hand
$2.3B
Total DebtLower is stronger
$617.4M
Stockholders' EquityBook value
$1.7B
$6.0B
Total Assets
$2.4B
$41.3B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
SF
SF
Q4 25
$2.3B
Q3 25
$1.0M
$3.2B
Q2 25
$16.0M
$1.9B
Q1 25
$17.8M
$2.7B
Q4 24
$22.7M
$2.6B
Q3 24
$29.5M
$1.9B
Q2 24
$90.3M
$2.6B
Q1 24
$69.1M
$3.4B
Total Debt
NTRA
NTRA
SF
SF
Q4 25
$617.4M
Q3 25
$617.2M
Q2 25
$617.0M
Q1 25
$616.8M
Q4 24
$616.6M
Q3 24
$616.4M
Q2 24
$1.1B
Q1 24
$1.1B
Stockholders' Equity
NTRA
NTRA
SF
SF
Q4 25
$1.7B
$6.0B
Q3 25
$1.3B
$5.8B
Q2 25
$1.2B
$5.6B
Q1 25
$1.2B
$5.5B
Q4 24
$1.2B
$5.7B
Q3 24
$878.5M
$5.6B
Q2 24
$836.5M
$5.4B
Q1 24
$794.1M
$5.3B
Total Assets
NTRA
NTRA
SF
SF
Q4 25
$2.4B
$41.3B
Q3 25
$1.8B
$41.7B
Q2 25
$1.8B
$39.9B
Q1 25
$1.7B
$40.4B
Q4 24
$1.7B
$39.9B
Q3 24
$1.6B
$38.9B
Q2 24
$1.5B
$37.8B
Q1 24
$1.5B
$38.3B
Debt / Equity
NTRA
NTRA
SF
SF
Q4 25
0.10×
Q3 25
0.11×
Q2 25
0.11×
Q1 25
0.11×
Q4 24
0.11×
Q3 24
0.11×
Q2 24
0.21×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
SF
SF
Operating Cash FlowLast quarter
$73.9M
$382.4M
Free Cash FlowOCF − Capex
$37.8M
$369.0M
FCF MarginFCF / Revenue
5.7%
32.7%
Capex IntensityCapex / Revenue
5.4%
1.2%
Cash ConversionOCF / Net Profit
1.56×
1.45×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
SF
SF
Q4 25
$73.9M
$382.4M
Q3 25
$59.4M
$338.3M
Q2 25
$37.6M
$607.5M
Q1 25
$44.5M
$-211.2M
Q4 24
$52.9M
$694.6M
Q3 24
$51.8M
$198.3M
Q2 24
$4.0M
$207.2M
Q1 24
$27.0M
$-609.7M
Free Cash Flow
NTRA
NTRA
SF
SF
Q4 25
$37.8M
$369.0M
Q3 25
$37.0M
$321.1M
Q2 25
$11.7M
$592.7M
Q1 25
$22.6M
$-227.8M
Q4 24
$34.8M
$677.2M
Q3 24
$35.5M
$185.6M
Q2 24
$-7.7M
$173.3M
Q1 24
$6.7M
$-619.4M
FCF Margin
NTRA
NTRA
SF
SF
Q4 25
5.7%
32.7%
Q3 25
6.2%
33.4%
Q2 25
2.1%
70.6%
Q1 25
4.5%
-27.0%
Q4 24
7.3%
73.9%
Q3 24
8.1%
22.9%
Q2 24
-1.9%
21.7%
Q1 24
1.8%
-80.6%
Capex Intensity
NTRA
NTRA
SF
SF
Q4 25
5.4%
1.2%
Q3 25
3.8%
1.8%
Q2 25
4.7%
1.8%
Q1 25
4.3%
2.0%
Q4 24
3.8%
1.9%
Q3 24
3.7%
1.6%
Q2 24
2.8%
4.2%
Q1 24
5.5%
1.3%
Cash Conversion
NTRA
NTRA
SF
SF
Q4 25
1.56×
1.45×
Q3 25
1.60×
Q2 25
3.92×
Q1 25
-3.99×
Q4 24
2.85×
Q3 24
1.25×
Q2 24
1.25×
Q1 24
-3.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons